Influenza H7N9 Virus Neuraminidase-Specific Human Monoclonal Antibodies Inhibit Viral Egress and Protect from Lethal Influenza Infection in Mice - Gilchuk, Iuliia M.; Bangaru, Sandhya; Gilchuk, Pavlo; Irving, Ryan P.; Kose, Nurgun; Bombardi, Robin G.; Thornburg, Natalie J.; Creech, C. Buddy; Edwards, Kathryn M.; Li, Sheng; Turner, Hannah L.; Yu, Wenli; et al. (Cell host & microbe, 2019)
Keywords: Animals; antibodies; Antibodies, Heterophile - pharmacology; Antibodies, Monoclonal - pharmacology; Antibodies, Neutralizing - pharmacology; Antibodies, Viral - pharmacology; B lymphocyte; Birds; epitopes; Epitopes - immunology; H7N9; Humans; influenza A virus; Influenza A Virus, H7N9 Subtype - drug effects; Influenza A Virus, H7N9 Subtype - immunology; Influenza in Birds - prevention & control; Influenza in Birds - virology; Influenza Vaccines - immunology; Influenza, Human - prevention & control; Influenza, Human - virology; Mice; monoclonal; neuraminidase; Neuraminidase - immunology; Orthomyxoviridae Infections - prevention & control; Orthomyxoviridae Infections - virology; Pre-Exposure Prophylaxis; Vaccination; Vaccines, Inactivated; Viral Proteins - immunology; Virus Release - drug effects; epitopes; pre-exposure prophylaxis; neuraminidase; B lymphocyte; antibodies; monoclonal; H7N9; influenza A virus